Pharmaceutical company GSK and Oxford University are teaming up to devise a groundbreaking cancer vaccine poised to stop the disease from developing in the first place. The ambition lies in ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

Geneticist Ian Tomlinson led the research from Oxford University in the United Kingdom. The researchers identified more than 250 genes that harbor mutations that cause colorectal cancer ...

GSK and the University of Oxford have joined hands to focus on the potential of cancer prevention through vaccination. The ...

Oxford Drug Design is a pre-clinical therapeutics spinout from Oxford University. The company discovers innovative treatments for cancer and other major diseases using computational methods.

OXcan was founded in 2020 by two Oxford University graduate students, Liu, a Canadian medical doctor by training with experience in cancer research, and president and COO Andreas Halner, who holds the ...

Immunotherapy is a fast-growing approach for cancer treatment ... than killer T cells. Enter Oxford Vacmedix and its ROPs. Back in 2000, while at Harvard University, the company’s founder ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...